protective role – Page 4 – Communicable Diseases Research

Dominant CD8 + T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination

SARS-CoV-2 감염에서 우세한 CD8 + T 세포 뉴클레오캡시드 표적화 및 백신 접종으로 인한 광범위한 스파이크 표적화

Immunology

Published on 2022-02-222022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

Article Commentary

Published on 2022-02-172022-10-28
Journal: Annals of Medicine [Category] COVID-19, COVID19(2023년), Fulltext, SARS,

[키워드] acute respiratory disease affected Antigen Autoimmune disease caused clinical status coeliac disease Complication Contact coronavirus disease COVID-19 COVID-19 pandemic diagnosed with COVID-19 diagnosis of COVID-19 diagnostic Effects enrolled evaluate examined flu-like symptom Follow-up Haplotype HLA HLA haplotype Hospitalization Human leukocyte antigen (HLA) Hypothesis intensive care leukocyte management no symptom Novel coronavirus pandemic participated Patient polymorphism presenting produced Protective protective role provided Psychological public health public health emergency question questionnaire reported Result role SARS-CoV SARS-CoV-2 SARS-COV-2 infection subject susceptibility the patient viral infections viruses
[DOI] 10.1080/07853890.2022.2039955 PMC 바로가기 [Article Type] Article Commentary

Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity

스트레스 대처 : Covid-19 심각도의 바이오 마커로서 미토 카인 GDF-15

Review

Published on 2022-02-162022-08-31
Journal: Frontiers in Immunology [Category] MERS, 바이오마커,

Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients

Pharmacology

Published on 2022-02-082022-10-31
Journal: Frontiers in Pharmacology [Category] COVID-19,

[키워드] acute respiratory distress addition Affect aggregates antagonists anti-inflammatory properties arachidonic acid Asthma auxiliary Bronchoalveolar lavage cardiovascular diseases characteristic characterized circulating COVID-19 COVID-19 patient COVID-19 patients disease Efficacy elevated endothelial cell damage expression feature implicated induced Inflammation inhibit inhibiting involved leukotriene leukotriene antagonists leukotrienes lipid mediator LTC metabolism Microvesicles Montelukast P-selectin plasma platelet activation pro-inflammatory protective role receptor reducing resulting severe COVID-19 patient suggested syndrome thrombotic tissue Tissue Factor treatment for COVID-19 widespread
[DOI] 10.3389/fphar.2022.784214 PMC 바로가기 [Article Type] Pharmacology

Anti-AT1R autoantibodies and prediction of the severity of Covid-19

항AT1R 자가항체와 코로나19 중증도 예측

Article

Published on 2022-02-012022-09-12
Journal: Human immunology [Category] COVID19(2023년), MERS, SARS, 진단,

A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?

Review

Published on 2022-01-292022-10-28
Journal: The Cochrane database of systematic reviews [Category] COVID-19,

[키워드] activating acute respiratory syndrome Anti-inflammatory Antioxidative antiviral property caused cellular homeostasis characterized clinical clinical manifestation complications coronavirus coronavirus disease COVID-19 Degradation dengue virus Ebola virus functions heme heme oxygenase 1 Hepatitis virus Human Human immunodeficiency virus IFN Infectious disease Inflammatory inflammatory disease influenza A virus Injury involved kidney lung matter nervous system oxidative Oxygenase pathway protective role rate-limiting enzyme Relevance Replication Research Respiratory failure respiratory syncytial virus SARS-CoV-2 Symptom systemic hyperinflammation the interferon viral infection viral infections Zika virus
[DOI] 10.3390/antiox11020276 PMC 바로가기 [Article Type] Review

Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?

계절성 코로나바이러스에 대한 기존 항체가 SARS-CoV-2 감염에 대한 보호 역할을 하고 COVID-19 중증도에 영향을 줍니까?

Commentary

Published on 2022-01-232022-09-11
Journal: EBioMedicine [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

[키워드] antibody COVID-19 Cross-protectivity Preexisting immunity protective role SARS-CoV-2 SARS-COV-2 infection sCoV seasonal coronavirus
[DOI] 10.1016/j.ebiom.2022.103831 PMC 바로가기 [Article Type] Commentary

Real-time individual benefit from social interactions before and during the lockdown: the crucial role of personality, neurobiology and genes

Article

Published on 2022-01-212022-10-04
Journal: Translational Psychiatry [Category] SARS, 유전자 메커니즘,

Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine

Article

Published on 2022-01-182022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] acute respiratory syndrome administration Analysis anti-S-RBD antibodies antibody Antibody titer Antiviral BNT162b2 mRNA BNT162b2 mRNA vaccine BNT162b2 vaccine Cell circulating coronavirus coronavirus disease COVID-19 detectable determinant died dose doses elapsed evaluate evaluated Factor HCW HCWs Health healthcare worker Healthcare workers induce Italy magnitude memory B Month Multivariate analysis pandemic participant pathway Protective antibody protective role provided recipient response Retrospective study robust S-RBD SARS-CoV-2 SARS-CoV-2 antigen SARS-COV-2 infection second dose serological severe COVID-19 significantly spike receptor-binding domain study participant T cell response the vaccine titer vaccination Vaccine was performed while worker
[DOI] 10.3390/vaccines10020141 PMC 바로가기 [Article Type] Article

B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications

Clinical Trial

Published on 2022-01-172022-10-04
Journal: Frontiers in Immunology [Category] 임상, 치료기술,

[키워드] acute respiratory syndrome administration age and sex All the patient Analysis anti-S anti-S antibody Antibody detection Antibody titers B-lymphocyte blood lymphocyte count CD20 cell-mediated response characterized circulating clinical Cohort comparable coronavirus Coronavirus-2 correlation COVID COVID-19 disease dose effective enrolled evaluate fingolimod General population GraphPad Prism healthy donor help Humoral response IFN-gamma IGRA Immunological response increase in lymphocyte Modifying mRNA vaccine Multiple multiple sclerosis Natalizumab NK-cell Ocrelizumab Patient pattern peptide peptides peripheral Peripheral blood Population protective role raised reduced reduction reported response Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination SARS-CoV-2 vaccine sclerosis second dose severe COVID-19 Spread symptoms of COVID-19 T-cell T-cell Response T-cell responses T-lymphocyte Treatment Vaccination strategy Vaccine vaccine immunogenicity was performed were assessed while
[DOI] 10.3389/fimmu.2021.796482 PMC 바로가기 [Article Type] Clinical Trial